Moxifloxacin Tillomed (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Tillomed, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and skin and skin structure infections in adult patients and is indicated for adult patients requiring systemic antibacterial therapy.

GNH USA supplies Moxifloxacin Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks and compliance with EU quality standards.

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections in the respiratory and skin pathways. - Community‑acquired pneumonia: eradicates the causative bacteria, leading to clinical improvement and reduced mortality. - Acute bacterial sinusitis: clears sinus infection, relieving congestion and facial pain. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load, improving cough and sputum production. - Skin and skin structure infections: eliminates pathogenic bacteria, promoting healing of cellulitis and abscesses.

Moxifloxacin may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, usually self‑limiting. - Headache: transient cranial discomfort.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reactions: anaphylaxis, angioedema, or bronchospasm.

When prescribing Moxifloxacin, consider the following precautions. - Renal impairment: assess kidney function and consider dose adjustment. - History of tendon disorders: avoid use due to increased risk of tendon rupture. - QT prolongation risk: monitor ECG in patients with cardiac disease or electrolyte abnormalities. - Concomitant antacids or multivitamins: separate administration by at least 2 hours to ensure absorption. - Pregnancy and lactation: prescribe only if potential benefit justifies potential risk to fetus or infant. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Moxifloxacin can interact with several medicines; awareness of the interaction level helps guide safe use.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce oral absorption of moxifloxacin. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Other fluoroquinolones: additive toxicity; concurrent use is not recommended.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased risk of tendon rupture; monitor for musculoskeletal pain. - Theophylline: moxifloxacin can raise plasma theophylline levels; monitor for toxicity. - Diabetes medications: possible alterations in blood glucose control; observe glycemic levels.